Seven of eight consumer staples companies beat EPS estimates in Q3 2026 earnings week: Earnings scorecard

Seven of eight S&P 500 consumer staples companies beat EPS estimates in Q3 2026, with Coca-Cola (KO), Altria (MO), and Colgate-Palmolive (CL) exceeding both EPS and revenue forecasts. Mondelez (MDLZ) beat EPS but missed revenue. Coca-Cola raised FY2026 EPS growth outlook to at least 11%.

Original reporting
Published Oct 31, 2026, 2:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 31, 2026, 2:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Seven of eight consumer staples companies beat EPS estimates in Q3 2026 earnings week: Earnings scorecard — source image
Decision brief

The 30-second read

$KOBullishLow
01

Why it matters

Strong earnings and guidance lifts across the sector may drive short‑term buying pressure in related stocks and ETFs.

02

Market read

The earnings beat cluster suggests a bullish tilt for consumer staples, potentially lifting sector indices and related ETFs.

03

What to watch

Potential input cost pressures and macro‑inflation could limit upside despite earnings beats.

Relevance 4/10Novelty 4/10Timing: post‑market today

Background

Q3 2026 earnings week for S&P 500 consumer staples delivered seven EPS beats out of eight companies.

Company-level read

Ticker impact

$KOBullishHigh confidence
Context

Coca‑Cola reported Q3 EPS beat and raised FY2026 EPS outlook, driving likely upside.

Expected impact

likely upside as market prices in the EPS beat and higher FY guidance

Evidence & confidence

EPS beat by $0.03 and FY2026 EPS outlook raised to at least 11% provide fresh, material information.

$MOBullishHigh confidence
Context

Altria posted an EPS beat and lifted FY2026 EPS guidance, adding a $1B share repurchase tranche.

Expected impact

likely upward pressure from the guidance lift and buyback expansion

Evidence & confidence

Guidance raised to $5.66‑$5.74 and a $1B repurchase program are new, material data.

$MDLZNeutralMedium confidence
Context

Mondelez beat EPS expectations but missed revenue, with shares up 3.5% after the release.

Expected impact

potential modest upside tempered by revenue shortfall

Evidence & confidence

EPS beat is fresh news, but revenue miss reduces the bullish impact.

$CLBullishHigh confidence
Context

Colgate‑Palmolive beat EPS and raised FY2026 EPS growth outlook to 5‑7%, prompting a positive reaction.

Expected impact

likely upside as market absorbs the raised EPS growth guidance

Evidence & confidence

Guidance lift and EPS beat are new, material information for investors.

Market effects

Consumer staples sector shows strong earnings momentum, supporting sector‑wide bullish bias.

U.S. market likely to see modest gains in consumer staples ETFs (e.g., XLP).

Positive U.S. consumer staples results may reinforce global risk‑on sentiment.

Counterpoint

Revenue miss at Mondelez and modest growth outlook at Colgate could signal over‑optimism.

Key entities

  • Coca‑Cola

    Reported EPS beat and raised FY2026 EPS outlook.

  • Altria

    Beat EPS, raised FY2026 guidance, expanded share repurchase.

  • Mondelez

    EPS beat but missed revenue expectations.

  • Colgate‑Palmolive

    EPS beat and raised FY2026 EPS growth outlook.

Related articles

$KOMed

Coca-Cola vs PepsiCo: Why the cola wars are far from over

KFC US will switch from PepsiCo to Coca-Cola in 2027, a deal valued at $500m in annual concentrate sales for PepsiCo. The move is part of KFC's strategy to boost US sales and reflects changing consumer preferences. Both companies compete for restaurant partnerships, with innovation and diverse portfolios being key factors.

$MDLZHighAI 8/10

MDLZ Q3 deep dive: disciplined pricing and emerging market expansion drive optimism

Mondelez (MDLZ) reported Q3 revenue of $9.97B, in line with estimates, and adjusted EPS of $0.78, beating estimates by 10.2%. Organic revenue rose 2.1% YoY, while sales volumes increased 1.8%. The company highlighted expansion in emerging markets, improved operational margins, and strategic pricing. Management expects continued growth from distribution expansion and productivity gains.

$MDLZMed

Mondelēz to acquire Undercover Snacks in expansion of better-for-you portfolio

Mondelēz International will acquire a majority stake in Undercover Snacks, expected to close in Q1 2027. Undercover will operate independently within Mondelēz's North America Ventures unit. The deal expands Mondelēz's healthier snack portfolio, according to CEO Dirk Van de Put. Mondelēz reported a 2.3% revenue increase to $9.97 billion in Q3, with Latin America seeing the fastest growth at 12%.

$CLMed

BofA raises Colgate-Palmolive stock price target to $105 on earnings

BofA Securities raised its price target for Colgate-Palmolive (NYSE:CL) to $105 from $100, citing strong earnings and updated fiscal 2026 guidance. The company reported Q3 earnings of $0.97 per share, exceeding estimates, with revenue of $5.37 billion. Colgate updated its outlook, expecting 4% to 5% net sales growth and 5% to 7% earnings growth. Analysts from UBS and Wells Fargo also raised their price targets.